Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS) (NCT05114096)

🧪 Interventions in This Study

• Celestone + placebo (DRUG)
• Celestone + Celestone (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (25 Sites)

• University of Calgary, Cumming School of Medicine — Calgary, Alberta
• Alberta Health Services; University of Alberta — Edmonton, Alberta
• Royal Columbian Hospital — New Westminster, British Columbia
• Fraser Health, University of British Columbia; Jim Pattison Outpatient Care and Surgery Centre — Surrey, British Columbia
• University of British Columbia; BC Women's Hospital — Vancouver, British Columbia
• Victoria General Hospital — Victoria, British Columbia
• University of Manitoba, Health Sciences Centre — Winnipeg, Manitoba
• University of Manitoba; St. Boniface General Hospital — Winnipeg, Manitoba
• Dr. Everett Chalmers Regional Hospital — Fredericton, New Brunswick
• The Moncton Hospital, Horizon Health Network — Moncton, New Brunswick
• Memorial University, Eastern Health — St. John's, Newfoundland and Labrador
• Dalhousie University; Izaak Walton Killam Health — Halifax, Nova Scotia
• McMaster University — Hamilton, Ontario
• Queen's University, Kingston General Hospital Health Sciences Centre — Kingston, Ontario
• Western University; London Health Sciences Centre, Victoria Hospital — London, Ontario
• University of Ottawa; The Ottawa Hospital — Ottawa, Ontario
• Mount Sinai Hospital — Toronto, Ontario
• Sunnybrook Health Sciences Center — Toronto, Ontario
• Hopital Maisonneuve Rosemont, CIUSSS de l'est de l'Ile de Montréal — Montreal, Quebec
• McGill University, McGill University Health Center, Royal Victoria Hospital — Montreal, Quebec
• Sir Mortimer B. Davis Jewish General Hospital; McGill University — Montreal, Quebec
• The Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal — Montreal, Quebec
• Université Laval, Centre de recherche du CHU de Québec — Québec, Quebec
• (CIUSSS de l'Estrie-CHUS); Université de Sherbrooke — Sherbrooke, Quebec
• University of Saskatchewan, Regina General Hospital — Saskatoon, Saskatchewan

📞 Contact the Study Coordinator

Phone: (905) 525-9140

Email: mcdonals@mcmaster.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Preterm Birth

• Targeting Human Milk Fortification to Improve Preterm Infant Growth and Brain Development — Boston, Massachusetts
• Omega Tots Long Term Follow-up — Columbus, Ohio
• Nurse-Family Partnership Impact Evaluation in South Carolina — Anderson, South Carolina
• Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India — Worcester, Massachusetts
• The Use of Wireless Sensors in Neonatal Intensive Care — Montreal, Quebec
• Music Intervention for Preterm Birth — New York, New York

Explore by condition: All Preterm Birth clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.